The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durability of response to venetoclax (VEN) in patients with CLL relapsed/refractory to ibrutinib and/or idelalisib.
 
John C. Byrd
Consulting or Advisory Role - Acerta Pharma
Research Funding - Acerta Pharma (Inst); Genentech (Inst); Janssen (Inst); Pharmacyclics (Inst)
 
William G. Wierda
Consulting or Advisory Role - Abbvie; Celgene; Emergent BioSolutions; Genentech/Roche; Genzyme; Gilead Sciences; GlaxoSmithKline/Novartis; Merck; Pharmacyclics; Sanofi
Research Funding - Abbvie; Acerta Pharma; Emergent BioSolutions; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics
 
Matthew Steven Davids
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Genentech; InCyte; Janssen; MEI Pharma; Merck; Pharmacyclics; TG Therapeutics
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); MEI Pharma (Inst); Pharmacyclics (Inst); Surface Oncology (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - TG Therapeutics
 
Michael Y. Choi
Consulting or Advisory Role - Abbvie/Genentech; Novartis
Speakers' Bureau - Abbvie/Genentech; Gilead Sciences; Pharmacyclics
Research Funding - Abbvie (Inst); Pharmacyclics (Inst)
 
Richard R. Furman
Honoraria - Genentech/Roche; Gilead Sciences; Janssen; Pharmacyclics
Consulting or Advisory Role - Abbvie; Genentech/Roche; Gilead Sciences; Janssen Biotech; Pharmacyclics
Speakers' Bureau - Genentech; Janssen; Pharmacyclics
Research Funding - Acerta Pharma
Travel, Accommodations, Expenses - Genentech/Roche; Gilead Sciences; Janssen; Pharmacyclics
 
Anthony R. Mato
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; Celgene; Janssen; Prime Oncology; TG Therapeutics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); DTRM (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Regeneron (Inst); TG Therapeutics (Inst)
 
Lang Zhou
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Maria E. Verdugo
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jalaja Potluri
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Steven Coutre
Stock and Other Ownership Interests - Pharmacyclics (I)
Consulting or Advisory Role - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; Janssen Oncology; Novartis; Pharmacyclics
Research Funding - Abbvie (Inst); Celgene (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Novartis (Inst); Pharmacyclics (Inst)
Travel, Accommodations, Expenses - abbvie; Celgene; Gilead Sciences; Janssen Oncology; Novartis; Pharmacyclics